Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort
International Journal of Chronic Obstructive Pulmonary Disease · 2025
DOI: 10.2147/copd.s502019 ↗At a glance
Journal article in International Journal of Chronic Obstructive Pulmonary Disease, 2025. Written by Pauline Puechoultres and 5 co-authors. Institution: Intensive Care Unit, Versailles Hospital, Le Chesnay, France. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Withholding Treatment, Intensive Care Units, Life Support Care. Cited 1 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC 3.0).
Topics: Intensivpflege, COPD
Abstract (original language)
Background
Data on withholding life-support (WLS) decisions during acute exacerbations of chronic obstructive pulmonary disease (COPD) in the intensive care unit (ICU) are scarce. This study aimed to identify factors associated with these decisions and their impact on mortality.
Methods
We conducted a monocentric retrospective cohort study on all patients admitted to our ICU between 2015 and 2021 for a severe acute exacerbation of COPD. Logistic multivariable regression analysis was performed.
Results
We included 463 patients of whom 128 (27.6%) had a decision of withholding of care. The 3-months mortality was 49.2% and 4.8% in the WLS group and in the no WLS group, respectively. Forty-eight patients (10.4%) had advanced healthcare directives. In multivariable analysis, factors associated with a decision of WLS were higher age (odds ratio [+10 years] = 1.93, p < 0.001), immunodeficiency (OR = 3.07, p < 0.001), higher Performance Status (PS) score (OR [+1 point] = 2.10, p < 0.001), long-term oxygen therapy (OR = 4.11, p < 0.001) and shock after ICU admission (OR = 2.43, p = 0.01). In multivariate analysis, factors significantly associated with 3-month mortality included decision of WLS during ICU (OR = 22.98, p < 0.001) and invasive mechanical ventilation (OR = 2.72, p < 0.001).
Conclusion
Approximately 30% of COPD patients underwent a decision to withhold life-sustaining treatment. Higher age, immunosuppression, increased PS score, and long-term oxygen therapy were significantly associated with this decision. Nearly half of the patients died within three months following a withholding of care decision.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Intensive Care Unit, Versailles Hospital, Le Chesnay, France.
- Intensive Care Unit, West Parisian Private Hospital, Ramsay-Générale de Santé, Trappes, France.
- Department for Research, Studies, Assessment and Statistics (DREES), French Ministry of Health, Paris, France.
- Department of Anesthesiology and Critical Care, APHP, Hôpital Européen Georges Pompidou, Paris, France; Université de Paris, INSERM, IThEM, Paris, France.
- Department of Anesthesiology and Intensive care, Marie Lannelongue Hospital, Le Plessis Robinson, France.
- University Paris-Saclay, UVSQ, INSERM, CESP, Villejuif, France.
Cite
APA
Puechoultres, P., Jamme, M., Abi-Abdallah, G., Diop, S., Legriel, S., & Ferré, A. (2025). Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s502019
Vancouver
Puechoultres P, Jamme M, Abi-Abdallah G, Diop S, Legriel S, Ferré A. Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort. International Journal of Chronic Obstructive Pulmonary Disease. 2025. doi:10.2147/copd.s502019
BibTeX
@article{Puechoultres2025,
author = {Puechoultres, Pauline and Jamme, Matthieu and Abi-Abdallah, Georges and Diop, Sylvain and Legriel, Stéphane and Ferré, Alexis},
title = {Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2025},
doi = {10.2147/copd.s502019}
}
EUVIMED